CHS Pharma Revenue

Biotechnology Research • United States • 1-10 Employees

CHS Pharma revenue & valuation

Annual revenue	$26,800,000
Revenue per employee	$8,933,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$85,800,000
Total funding	No funding

Key Contact at CHS Pharma

David Rubin

Director of Investor Relations

Company overview

Headquarters	United States
Phone number	+15617489393
Website	chspharma.com
NAICS	541714
SIC	283
Keywords	Stroke, Actinic Keratosis, Myocardial Infarction, Dry Macular Degeneration
Employees	1-10
Socials

About CHS Pharma

CHS Pharma Inc. on Feb. 2013 acquired its Intellectual Property Portfolio from Florida Atlantic University and Hospital for Special Surgery. The IP portfolio is considered a platform technology and currently consists of 4 issued patents, 2 allowed, and 8 applications pending. The mentioned portfolio covers drug candidates for treatments of Actinic Keratosis (Basal and Squamous cell Carcinomas in EU patent), Dry Macular Degeneration, Myocardial Infarction, and Ischemic Stroke. CHS's corporate development strategy is to develop the drug candidates up to Phase II clinical studies and at that point in time either form a strategic partnership or license the technology to other pharmaceutical companies.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Director

Funding Data

CHS Pharma has never raised funding before.

CHS Pharma Tech Stack

Discover the technologies and tools that power CHS Pharma's digital infrastructure, from frameworks to analytics platforms.

Lodash

JavaScript libraries

GoDaddy Website Builder

CMS

Open Graph

Miscellaneous

HSTS

Security

React

JavaScript frameworks

Immutable.js

JavaScript libraries

PWA

Miscellaneous

Frequently asked questions

CHS Pharma is located in US.

You can reach CHS Pharma at +15617489393.

CHS Pharma generates an estimated annual revenue of $26,796,782. This revenue figure reflects the company's market position and business performance in its industry.

CHS Pharma has an estimated valuation of $85,800,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

CHS Pharma has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at CHS Pharma

David Rubin

Director of Investor Relations

4.8

40,000 users